ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2018
Updated Correlation of 22C3-PD-L1 ≥50% Expression with Driver Oncogene Mutations and Response to Pembrolizumab in the Kinase Inhibitor-Resistant Setting.
Deepa Rangachari et al.PubMed ↗Publisher ↗
No numbers read from the abstract.